CorMedix Inc. (CRMD) › Cash & EquivalentsCorMedix Inc. (CRMD) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2006: $02009: $1.51M2010: $8.28M2011: $1.99M2012: $835.5K2013: $2.37M2014: $4.34M2015: $11.82M2016: $8.06M2017: $10.38M2018: $17.62M2019: $16.35M2020: $41.91M2021: $53.32M2022: $43.15M2023: $43.64M2024: $40.65M2025: $144.84M$144.84M2006Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$144.84M+256.3%2024$40.65M-6.9%2023$43.64M+1.1%2022$43.15M-19.1%2021$53.32M+27.2%2020$41.91M+156.3%2019$16.35M-7.2%2018$17.62M+69.8%2017$10.38M+28.7%2016$8.06M-31.8%2015$11.82M+172.3%2014$4.34M+82.8%2013$2.37M+184.1%2012$835.5K-57.9%2011$1.99M-76.0%2010$8.28M+450.3%2009$1.51M—2006$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share